Amid growing pressure from investors and proxy advisory firms to strengthen the connection between pay and performance, drug and medical supply distributor McKesson last week become the latest company to make sweeping changes to its executive compensation program.

Learn More
Already a member? Sign in to an existing account.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...